<?xml version="1.0" encoding="UTF-8"?>
<p>Currently, no effective vaccines or drugs have been approved for clinical use, although inhibitors designed to treat infections in vivo are being developed. In order to increase the speed of development of potential treatments available, two approaches are generally employed. Firstly, testing of current antiviral drugs and medications used to treat other infections or other disease states. The second approach is to develop novel agents based on current information and understanding of the particular coronavirus targeted [
 <xref ref-type="bibr" rid="CR1">1</xref>].
</p>
